2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$544.19+$5.88 (+1.09%)
Price as of Jun 23, 2026 5:39 PM EDT- $22.8BMarket Cap
- 87.96%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$544.19+$5.88 (+1.09%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $538.30 | ||
Change | +$1.71 (+0.32%) | ||
Open | $541.25 | ||
High | $541.53 | ||
Low | $533.49 | ||
Previous Close | $536.59 | ||
Volume | 620,875 | ||
30-Day Average Volume | 580,532 | ||
1-Week Change | -2.05% | ||
1-Month Change | -5.30% | ||
1-Year Change | 87.96% | ||
3-Year Change | 139.00% | ||
5-Year Change | 197.63% | ||
Fundamentals | |||
Shares Outstanding | 42.4M | ||
Total Assets | $6.7B | ||
Market Cap | $22.8B | ||
Enterprise Value | $21.8B | ||
Period: QTR TTM FY | |||
Revenue | $781.5M | ||
Net Income | $274.9M | ||
Free Cash Flow | $362.5M | ||
EBIT | $318.3M | ||
EBITDA | $340.9M | ||
Net Working Capital | $2.3B | ||
EPS | $5.82 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 4 | ||
P/E | 92 | ||
PEG | -4 | ||
Price/Free Cash Flow | 63 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue